Optomed Oyj

OPTOMED

FI4000410881

Advanced Medical Equipment & Technology

Real-time Estimate Cboe Europe Other stock markets 06:13:46 2024-05-13 am EDT			5-day change	1st Jan Change
5.93 ^EUR	+8.41%		+18.91%	+58.28%

May. 07	Transcript : Optomed Oyj, Q1 2024 Earnings Call, May 07, 2024
May. 07	Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Optomed Provides Revenue Guidance for the Full Year of Fiscal 2021

February 18, 2021 at 02:00 am EST

Optomed provided revenue guidance for the full year of fiscal 2021. The company expects its full year 2021 revenue to grow compared to 2020.

Latest news about Optomed Oyj

Transcript : Optomed Oyj, Q1 2024 Earnings Call, May 07, 2024	May. 07
Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Optomed USA, Inc. Introduces Optomed Aurora AEYE	May. 01	CI
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod	May. 01	RE
Optomed Plc Announces Optomed Aurora with AEYE Receives U.S. Food & Drug Administration Clearance in US	Apr. 30	CI
Optomed Plc Provides Revenue Guidance for the Full Year of 2024	Apr. 30	CI
Transcript : Optomed Oyj, 2023 Earnings Call, Feb 15, 2024	Feb. 15
Optomed Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Optomed Oyj Provides Revenue Guidance for the Full Year 2024	Feb. 15	CI
Optomed Oyj Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Optomed Oyj Announces Nomination Board	Jan. 10	CI
Transcript : Optomed Oyj, Nine Months 2023 Earnings Call, Nov 03, 2023	Nov. 03
Optomed Oyj Provides Revenue Guidance for the Year 2023	Nov. 03	CI
Optomed Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI
Optomed to Raise EUR4 Million Via Share Issue	23-09-21	MT
Optomed plc Announces Composition of Its Nomination Board	23-09-12	CI
Optomed to Supply Large Diabetic Retinopathy Screening Solution to Spain	23-08-18	CI
Transcript : Optomed Oyj, H1 2023 Earnings Call, Aug 04, 2023	23-08-04
Optomed Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Optomed Appoints Juho Himberg as the New CEO, Effective October 1, 2023	23-08-03	CI
Optomed Announces CEO Transition Plan	23-06-14	CI
Optomed Oyj Approves Board Changes	23-05-10	CI
Finland's Optomed Enters Distribution Partnership Deal With Thirona Retina	23-05-09	MT
Transcript : Optomed Oyj, Q1 2023 Earnings Call, May 05, 2023	23-05-05
Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI

Optomed Oyj is a Finland-based medical technology company and a producer of handheld fundus cameras globally. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Ratings for Optomed Oyj

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.47 EUR

Average target price

6.633 EUR

Spread / Average Target

+21.27%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OPTOMED OYJ	+58.28%	105M
THERMO FISHER SCIENTIFIC	+11.73%	226B
DANAHER CORPORATION	+9.53%	188B
INTUITIVE SURGICAL, INC.	+14.63%	137B
BOSTON SCIENTIFIC CORPORATION	+27.47%	108B
SIEMENS HEALTHINEERS AG	+0.61%	63.19B
EDWARDS LIFESCIENCES CORPORATION	+13.73%	52.26B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+4.86%	51B
AGILENT TECHNOLOGIES, INC.	+7.72%	43.89B
GE HEALTHCARE TECHNOLOGIES INC.	+7.86%	38.07B

Other Advanced Medical Equipment & Technology

Optomed Oyj

Equities

OPTOMED

FI4000410881

Advanced Medical Equipment & Technology

Optomed Provides Revenue Guidance for the Full Year of Fiscal 2021

Latest news about Optomed Oyj

Chart Optomed Oyj

Company Profile

Income Statement Evolution

Ratings for Optomed Oyj

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology